Ganaxolone, an approved therapy for CDKL5-deficiency disorder, is an inhibitor of PTP1B - Imanol Zubiete-Franco; Qingting Hu; Steven R. Alves; Raditya Utama; Nicholas K. Tonks (Journal of Biological Chemistry, 2026)